News & Perspective

Jun 20, 2007

Jun 20, 2007

Japanese to study behavioral effects of Tamiflu

(CIDRAP News) – The company that markets oseltamivir (Tamiflu) in Japan has announced it will launch new studies to explore whether the antiviral drug contributes to adverse psychiatric and neurologic events in teenagers.